[1]
SYAHRANI, R.A., LOUISA, M. and WANANDI, S.I. 2019. SENSITIVITY OF BREAST CANCER STEM CELLS (CD24-/CD44+) TO DOXORUBICIN IS ASSOCIATED WITH OXIDATIVE STRESS STATUS. International Journal of Applied Pharmaceutics. 11, 6 (Dec. 2019), 91-96. DOI:https://doi.org/10.22159/ijap.2019.v11s6.33555.